Clinical Trial Update: The RApid Switch From 1st Generation Somatostatin Analogues to PaSireOtiDe In Acromegaly

View source ↗

Summary

This clinical trial update notes a rapid switch from first-generation somatostatin analogues to pasireotide in patients with acromegaly, with the study currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• Lanreotide (lanreotide)
• OCTREOTIDE (OCTREOTIDE ACETATE)
• Pasireotide (pasireotide)

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Acromegaly | Status: RECRUITING